Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres

被引:6
|
作者
Lee, Jimin [1 ]
Sah, Hongkee [1 ]
机构
[1] Ewha Womans Univ, Coll Pharm, 52 Ewhayeodaegil, Seoul 03760, South Korea
关键词
poly-d; l-lactide-co-glycolide; microspheres; nanoparticles; wet milling; PHARMACEUTICAL NANOCRYSTALS; NANOSUSPENSION; FORMULATIONS; DELIVERY;
D O I
10.3390/pharmaceutics14081540
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Currently, emulsification-templated nanoencapsulation techniques (e.g., nanoprecipitation) have been most frequently used to prepare poly-d,l-lactide-co-glycolide (PLGA) nanoparticles. This study aimed to explore a new top-down process to produce PLGA nanoparticles. The fundamental strategy was to prepare spongelike PLGA microspheres with a highly porous texture and then crush them into submicron-sized particles via wet milling. Therefore, an ethyl formate-based ammonolysis method was developed to encapsulate progesterone into porous PLGA microspheres. Compared to a conventional solvent evaporation process, the ammonolysis technique helped reduce the tendency of drug crystallization and improved drug encapsulation efficiency accordingly (solvent evaporation, 27.6 +/- 4.6%; ammonolysis, 65.1 +/- 1.7%). Wet milling was performed on the highly porous microspheres with a D-50 of 64.8 mu m under various milling conditions. The size of the grinding medium was the most crucial factor for our wet milling. Milling using smaller zirconium oxide beads (0.3 similar to 1 mm) was simply ineffective. However, when larger beads with diameters of 3 and 5 mm were used, our porous microspheres were ground into submicron-sized particles. The quality of the resultant PLGA nanoparticles was demonstrated by size distribution measurement and field emission scanning electron microscopy. The present top-down process that contrasts with conventional bottom-up approaches might find application in manufacturing drug-loaded PLGA nanoparticles.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Biodegradation and biocompatibility of PLA and PLGA microspheres
    Anderson, James M.
    Shive, Matthew S.
    ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 : 72 - 82
  • [42] Tolerance levels of PLGA microspheres in the eyes
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2017, 266 : 365 - 365
  • [43] Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles
    Li, Xue
    Radomski, Anna
    Corrigan, Owen I.
    Tajber, Lidia
    Menezes, Fabio De Sousa
    Endter, Sibylle
    Medina, Carlos
    Radomski, Marek W.
    NANOMEDICINE, 2009, 4 (07) : 735 - 746
  • [44] Stability and physicochemical characteristics of PLGA, PLGA:poloxamer and PLGA:poloxamine blend nanoparticles -: A comparative study
    Santander-Ortega, M. J.
    Csaba, N.
    Alonso, M. J.
    Ortega-Vinuesa, J. L.
    Bastos-Gonzalez, D.
    COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2007, 296 (1-3) : 132 - 140
  • [45] Surface modification of PLGA microspheres for targeting
    Lathia, JD
    El-Sherif, D
    Dhoot, NO
    Wheatley, MA
    PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2002, : 225 - 226
  • [46] Minimizing acylation of peptides in PLGA microspheres
    Zhang, Ying
    Schwendeman, Steven P.
    JOURNAL OF CONTROLLED RELEASE, 2012, 162 (01) : 119 - 126
  • [47] Preparation and evaluation of 5-FU/PLGA/gene nanoparticles
    Hu, YX
    Chang, J
    Guo, Y
    Yuan, XB
    Kang, CS
    Pu, PY
    ASBM6: ADVANCED BIOMATERIALS VI, 2005, 288-289 : 147 - 150
  • [48] Preparation and Optimization of Dry PLGA Nanoparticles by Spray Drying Technique
    Bhambere, Deepak
    Shirivastava, Birendra
    Sharma, Pankaj
    Bukane, Nisha
    Gide, Paraag
    PARTICULATE SCIENCE AND TECHNOLOGY, 2013, 31 (05) : 533 - 540
  • [49] Preparation and Evaluation of PLGA-Coated Capsaicin Magnetic Nanoparticles
    Mrudhula Baskaran
    Padmamalini Baskaran
    Navamoney Arulsamy
    Baskaran Thyagarajan
    Pharmaceutical Research, 2017, 34 : 1255 - 1263
  • [50] Sustainable preparation of anti-inflammatory atorvastatin PLGA nanoparticles
    Grune, Christian
    Zens, Clara
    Czapka, Anna
    Scheuer, Karl
    Thamm, Jana
    Hoeppener, Stephanie
    Jandt, Klaus D.
    Werz, Oliver
    Neugebauer, Ute
    Fischer, Dagmar
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 599